STOCK TITAN

Kazia Therapeutics (KZIA) Revenue by Year

KZIA NASDAQ

Kazia Therapeutics Limited generated $28K in revenue in fiscal year 2025. This represents a decrease of 98.2% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Kazia Therapeutics Limited has filed alongside them.

FY2025 annual
Revenue $28K
YoY -98.2%
Source SEC Filings (20-F/6-K) Latest period Q2 FY2026, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KZIA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Revenue$28K-98.2%$1.5Mn/m$0n/m$0-100.0%$11.4MN/AN/A$88K-53.9%$191K-36.7%$302K

KZIA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'266-KQ4'256-KQ2'256-KQ4'2420-FQ2'246-KQ4'2320-FQ2'236-KQ4'2220-FQ4'2120-FQ4'2020-FQ4'1920-FQ4'1820-F
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Kazia Therapeutics Limited financials

Frequently Asked Questions

Kazia Therapeutics Limited generated $28K in revenue in fiscal year 2025.

Kazia Therapeutics Limited (KZIA) revenue fell by 98.2% year over year, from $1.5M to $28K in fiscal year 2025.

Across the 10 fiscal years this page covers, Kazia Therapeutics Limited (KZIA) revenue went from $302K in fiscal year 2016 to $28K in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Kazia Therapeutics Limited (KZIA) reported on that line in every period on record.